Vaccine leptospirosis concentrated inactivated liquid (Vaccinum Leptospirosum concentratum inactivum fluidum)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceVaccine for prevention of leptospirosisVaccine for prevention of leptospirosis
Dosage form: & nbspsubcutaneous suspension
Composition:One dose (0.5ml) of leptospirosis concentrated inactivated liquid vaccine contains a mixture of inactivated concentrated leptospira cultures of four serological groups: Leptospira interrogans Icterohaemorrhagiae copenhageni, L. interrogans Grippotyphosa grippotyphosa, L. interrogans Pomona mozdoc, L. interrogans Sejroe sejroe; formalin - preservative in an amount not exceeding 0.03%.
Description:

The vaccine is a colorless slightly opalescent liquid with a precipitate that breaks easily when shaken.

Pharmacotherapeutic group:MIBP vaccine
ATX: & nbsp

J.07.A   Vaccines for the prevention of bacterial infections

J.07.A.X   Other vaccines for the prevention of bacterial infections

Pharmacodynamics:The vaccine causes development spcipheric immunity lasting one year.
Indications:

Prevention of leptospirosis from 7 years of age.

Vaccinations are subject to persons performing the following works:

- for the procurement, storage, processing of raw materials and livestock products obtained from farms located on enzootic leptospirosis territories;

- slaughter of livestock, a patient with leptospirosis, harvesting and processing of meat and meat products obtained from patients with leptospirosis of animals;

- on the capture and maintenance of neglected animals;

- Working with live cultures of the causative agent of leptospirosis.

Contraindications:

- Acute infectious and non-infectious diseases, chronic diseases in the acute stage - vaccinations are given no earlier than 1 month after recovery (remission);

- a strong reaction to the previous administration of leptospirosis vaccine (temperature above 40 ° C, hyperemia, infiltration with a diameter of more than 8 cm);

- bronchial asthma, severe allergic reactions in the history of food, medications and other drugs;

- disease of the endocrine system;

- Malignant neoplasms and malignant diseases of the blood;

- diseases of the nervous system with progredient course, epilepsy with frequent seizures;

- pregnancy;

- breast-feeding.

In each individual case of a severe physical illness not contained in this list,questions about the indication for vaccination are decided by the doctor.

All persons before vaccination should be examined by a doctor (paramedic) with obligatory thermometry.

Dosing and Administration:

The vaccine is injected subcutaneously into the area of ​​the lower corner of the scapula.

Before the injection, the ampoule with the preparation is shaken thoroughly.

Vaccination is carried out with a single dose of 0.5 ml. Revaccination is carried out after 1 year with a single dose of 0.5 ml.

Disposable preparations with broken integrity of ampoules or lack of labeling are unsuitable for use when changing physical properties (color, transparency, presence of flakes), with expired shelf life and with improper storage.

Opening of ampoules and the procedure for administering the vaccine are carried out with strict adherence to aseptic rules. The drug in the opened ampoule is not subject to storage.

Side effects:

Leptospira vaccine is one of the drugs with low reactogenicity.

In rare cases, the first day after vaccination, a local reaction in the form of hyperemia and infiltration up to a diameter of 30 mm, subfebrile temperature is possible.

Interaction:

It is allowed to introduce inactivated vaccines used in the calendar of preventive vaccinations for epidemiological indications and the national calendarpreventive vaccinations in one day with different syringes in different parts of the body.

Special instructions:

When vaccine is used, the vaccine should be monitored for at least 30 minutes, and vaccination sites should be provided with anti-shock therapy.

Form release / dosage:Suspension for subcutaneous administration.
Packaging:

For 0.5 ml (1 dose) or 1.5 ml (3 doses) of the vaccine in glass ampoules.

10 ampoules per pack, instruction manual.

Storage conditions:

In accordance with SP 3.3.2.1248-03 at a temperature of 2 to 8 ° C. Do not freeze.

Keep out of the reach of children.

Shelf life:

2 years.

The drug with expired shelf life is not subject to application.

Terms of leave from pharmacies:For hospitals
Registration number:P N002481 / 01-2003
Date of registration:09.09.2008 / 25.04.2012
Expiration Date:Unlimited
The owner of the registration certificate:Rostov Research Institute of Microbiology and Parasitology of Rospotrebnadzor, FSUE Rostov Research Institute of Microbiology and Parasitology of Rospotrebnadzor, FSUE Russia
Manufacturer: & nbsp
Information update date: & nbsp12.01.2017
Illustrated instructions
    Instructions
    Up